Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Towards Diagnosis of Secondary Sarcopenia as a Comorbidity in Heart Failure: a Multivariate Biomarker Approach

NCT06217640 is registered in ClinicalTrials.gov with University of Liverpool as lead sponsor.

NCT NCT06217640
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06217640 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Towards Diagnosis of Secondary Sarcopenia as a Comorbidity in Heart Failure: a Multivariate Biomarker Approach
Lead sponsor
University of Liverpool
Phase
Observational
Overall status
Active, not recruiting
Start date
August 1, 2023
Completion date
December 30, 2025
Enrollment
80 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

body weight, frailty, heart failure, muscle weakness, sarcopenia